Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Trial Profile

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs Exenatide (Primary)
  • Indications Gestational diabetes
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Aug 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 06 Aug 2013 Actual initiation date changed from 1 Mar 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 06 Aug 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top